Chronic spontaneous urticaria Trials in Pittsburgh, United States
Conditions / Chronic spontaneous urticaria / Pittsburgh, United States
Chronic spontaneous urticaria is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03580356 | A Phase III Study of and Efficacy of Ligelizumab in the Treatment of CSU in Adolescents and Adults Inadequately Controlled With H1-antihistamines. | COMPLETED | PHASE3 |
| NCT03661866 | A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC | RECRUITING | — |
| NCT05513001 | An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05795153 | A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks. | COMPLETED | PHASE3 |
| NCT04180488 | Dupilumab for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are naïve to, Intolerant of, or Incomplete Responders to Omalizumab (LIBERTY-CSU CUPID) | COMPLETED | PHASE3 |
| NCT05677451 | 24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up | RECRUITING | — |
| NCT04210843 | Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab | TERMINATED | PHASE3 |
| NCT06077773 | Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria | TERMINATED | PHASE2 |
| NCT05032157 | A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines | COMPLETED | PHASE3 |
| NCT06931405 | Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) | RECRUITING | PHASE2 |